Enrique M. Saldarriaga
Economist & Evidence-to-Decision Expert
I am a health economist and decision scientist specializing in evidence-to-decision research. I combine economic evaluation, causal inference, mathematical modeling, preference research, and real-world evidence to help organizations determine which interventions work, for whom, at what cost, and under what conditions.
My work begins with a consequential policy or investment decision. I collaborate with stakeholders to identify evidence gaps, evaluate potential solutions, and characterize impact, affordability, equity, and uncertainty. I then translate the findings into actionable recommendations about how limited resources should be allocated and whether interventions should be adopted, adapted, or scaled.
Explore my work to see how rigorous analysis can turn evidence into better policies, investments, and outcomes.
Research Interests
- Evidence-to-decision and implementation research
- Health economics and comparative economic evaluation
- Policy, program, and portfolio evaluation
- Healthcare access, equity, and resource allocation
- Decision modeling under uncertainty
- Infectious disease and population-impact modeling
Skills
Education
-
PhD Health Economics (Jun 2022)
University of Washington, Seattle, WA
-
MS Epidemiology (2015)
University Cayetano Heredia, Lima, Peru
-
BS Economics (2011)
University of the Pacific, Lima, Peru
Recent Publications
Using machine learning to identify COVID-19 vaccine-hesitancy predictors in the USA.
In BMJ Public Health, 2023.
An incomplete step in the right direction: Peru's National Institute of Health establishes cost-effectiveness threshold.
In Revista De Saude Publica, 2023.
Finding and treating early-stage HIV infections: A cost-effectiveness analysis of the Sabes study in Lima, Peru.
In The Lancet Regional Health - Americas, 2022.
Assessing payers’ preferences for Real World Evidence in the United States: A Discrete Choice Experiment.
In Value in Health, 2022.
HIV-Prevalence Mapping Using Small Area Estimation in Kenya, Tanzania, and Mozambique at the First Sub-National Level.
In Annals Of Global Health, 2021.